187 related articles for article (PubMed ID: 22396166)
1. FGF23 in chronic kidney disease.
Wahl P; Wolf M
Adv Exp Med Biol; 2012; 728():107-25. PubMed ID: 22396166
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor 23 and the future of phosphorus management.
Wolf M
Curr Opin Nephrol Hypertens; 2009 Nov; 18(6):463-8. PubMed ID: 19770756
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor 23 and disordered vitamin D metabolism in chronic kidney disease: updating the "trade-off" hypothesis.
Gutiérrez OM
Clin J Am Soc Nephrol; 2010 Sep; 5(9):1710-6. PubMed ID: 20507957
[TBL] [Abstract][Full Text] [Related]
4. Forging forward with 10 burning questions on FGF23 in kidney disease.
Wolf M
J Am Soc Nephrol; 2010 Sep; 21(9):1427-35. PubMed ID: 20507943
[TBL] [Abstract][Full Text] [Related]
5. What would we like to know, and what do we not know about fibroblast growth factor 23?
Cozzolino M; Galassi A; Apetrii M; Covic A
J Nephrol; 2011; 24(6):696-706. PubMed ID: 21786227
[TBL] [Abstract][Full Text] [Related]
6. Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease.
Hasegawa H; Nagano N; Urakawa I; Yamazaki Y; Iijima K; Fujita T; Yamashita T; Fukumoto S; Shimada T
Kidney Int; 2010 Nov; 78(10):975-80. PubMed ID: 20844473
[TBL] [Abstract][Full Text] [Related]
7. New insights into the role of fibroblast growth factor 23 in chronic kidney disease.
Nakai K; Komaba H; Fukagawa M
J Nephrol; 2010; 23(6):619-25. PubMed ID: 20658451
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor 23 and the heart.
Faul C
Curr Opin Nephrol Hypertens; 2012 Jul; 21(4):369-75. PubMed ID: 22531163
[TBL] [Abstract][Full Text] [Related]
9. FGF23: a key player in mineral and bone disorder in CKD.
Komaba H; Fukagawa M
Nefrologia; 2009; 29(5):392-6. PubMed ID: 19820750
[TBL] [Abstract][Full Text] [Related]
10. Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease.
Stubbs J; Liu S; Quarles LD
Semin Dial; 2007; 20(4):302-8. PubMed ID: 17635819
[TBL] [Abstract][Full Text] [Related]
11. A blueprint for randomized trials targeting phosphorus metabolism in chronic kidney disease.
Isakova T; Gutiérrez OM; Wolf M
Kidney Int; 2009 Oct; 76(7):705-16. PubMed ID: 19606082
[TBL] [Abstract][Full Text] [Related]
12. Reciprocal control of 1,25-dihydroxyvitamin D and FGF23 formation involving the FGF23/Klotho system.
Prié D; Friedlander G
Clin J Am Soc Nephrol; 2010 Sep; 5(9):1717-22. PubMed ID: 20798257
[TBL] [Abstract][Full Text] [Related]
13. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
14. Parathyroid Klotho and FGF-receptor 1 expression decline with renal function in hyperparathyroid patients with chronic kidney disease and kidney transplant recipients.
Krajisnik T; Olauson H; Mirza MA; Hellman P; Akerström G; Westin G; Larsson TE; Björklund P
Kidney Int; 2010 Nov; 78(10):1024-32. PubMed ID: 20686451
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast growth factor 23 and bone metabolism in children with chronic kidney disease.
van Husen M; Fischer AK; Lehnhardt A; Klaassen I; Möller K; Müller-Wiefel DE; Kemper MJ
Kidney Int; 2010 Jul; 78(2):200-6. PubMed ID: 20407479
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in the rapidly evolving field of fibroblast growth factor 23 in chronic kidney disease.
Zisman AL; Wolf M
Curr Opin Nephrol Hypertens; 2010 Jul; 19(4):335-42. PubMed ID: 20583336
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease.
Gutierrez O; Isakova T; Rhee E; Shah A; Holmes J; Collerone G; Jüppner H; Wolf M
J Am Soc Nephrol; 2005 Jul; 16(7):2205-15. PubMed ID: 15917335
[TBL] [Abstract][Full Text] [Related]
18. Is fibroblast growth factor 23 a harbinger of mortality in CKD?
Stubbs JR; Egwuonwu S
Pediatr Nephrol; 2012 May; 27(5):697-703. PubMed ID: 21390563
[TBL] [Abstract][Full Text] [Related]
19. FGF23 and mineral metabolism, implications in CKD-MBD.
Rodríguez M; López I; Muñoz J; Aguilera-Tejero E; Almaden Y
Nefrologia; 2012 May; 32(3):275-8. PubMed ID: 22592418
[No Abstract] [Full Text] [Related]
20. Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study.
Fliser D; Kollerits B; Neyer U; Ankerst DP; Lhotta K; Lingenhel A; Ritz E; Kronenberg F; ; Kuen E; König P; Kraatz G; Mann JF; Müller GA; Köhler H; Riegler P
J Am Soc Nephrol; 2007 Sep; 18(9):2600-8. PubMed ID: 17656479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]